Favorable safety and efficacy profiles of α-1-antitrypsin in steroid- and ruxolitinib-refractory acute graft-<i>versus</i>-host disease of the gastrointestinal tract: a retrospective, single center study

類似資料

• FLAG-IDA-Venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world study
  著者:: Baher Krayem, 等
  出版事項: (2026-02-01)
• Favorable safety and efficacy profiles of α-1-antitrypsin in steroid- and ruxolitinib-refractory acute graft-<i>versus</i>-host disease of the gastrointestinal tract: a retrospective, single center study
  著者:: Dana Yehudai-Ofir, 等
  出版事項: (2026-04-01)
• The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
  著者:: Israel Henig, 等
  出版事項: (2020-11-01)
• Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
  著者:: Rabia Shahswar, 等
  出版事項: (2023-07-01)
• Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia
  著者:: Julia S. Lee, 等
  出版事項: (2023-06-01)